Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Apnea

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Apnea in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
"Methylxanthines like caffeine and theophylline have long been used to treat apnea of prematurity."3.80Methylxanthine reversal of opioid-induced respiratory depression in the neonatal rat: mechanism and location of action. ( Ballanyi, K; Ciechanski, P; Mosca, EV; Roy, A; Scheibli, EC; Wilson, RJ, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mosca, EV1
Ciechanski, P1
Roy, A1
Scheibli, EC1
Ballanyi, K1
Wilson, RJ1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Apnea

ArticleYear
Methylxanthine reversal of opioid-induced respiratory depression in the neonatal rat: mechanism and location of action.
    Respiratory physiology & neurobiology, 2014, Aug-15, Volume: 200

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Animals, Newborn; Apn

2014